PALI - PALISADE BIO, INC.

QQQ $ 468.16 $ -5.41 (-1.13 %)

DIA $ 411.36 $ -1.55 (-0.38 %)

SPY $ 558.32 $ -3.26 (-0.58 %)

TLT $ 97.88 $ -0.12 (-0.12 %)

GLD $ 231.76 $ -1.64 (-0.7 %)

Previous Close

$ 3.55

Open

Bid

$ 3.49 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 3.30 - $ 28.95

Volume

4,523

Average Volume

Market Cap

4.2M

Beta (5Y Monthly)

$ 0.97

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-26-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-22-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-13-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-23-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-22-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-15-2020	03-31-2020	10-Q
19	03-27-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-14-2019	03-31-2019	10-Q
23	03-22-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	04-02-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-23-2017	12-31-2016	10-K
32	11-08-2016	09-30-2016	10-Q
33	08-11-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-14-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-10-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	03-16-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Palisade Bio Q2 2024 GAAP EPS $(3.32) Miss...
08/13/2024 12:18:51

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(3.32) per share which missed the analyst consensus estimate of $(3.11...

Palisade Bio Selects Dose Levels For Upcom...
08/08/2024 12:44:42

– Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) on track to commence before year end– ...

Palisade Bio shares are trading higher aft...
07/29/2024 13:49:06

Palisade Bio Completes Microbiome Study Co...
07/29/2024 12:42:22

Findings demonstrate that the microbiome and enzymes are sufficient in mouse, dog, and Normal Healthy Volunteers (NHV) and Ulce...

Palisade Bio shares are trading higher aft...
07/19/2024 12:33:41

Palisade Bio Announces European Patent Off...
07/19/2024 12:32:47

Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programsPatent includes broad claims for "Gut...

Palisade Bio shares are trading higher aft...
07/11/2024 12:06:19

Palisade Bio Completes Pivotal Nonclinical...
07/11/2024 12:03:24

Palisade Bio Provides Update On Collaborat...
06/21/2024 12:18:54

– Collaboration advancing Palisade Bio's precision medicine approach through access to cutting-edge expertise and tools in ...

Palisade Bio Announces Canadian Intellectu...
06/11/2024 12:31:22

PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposureCompany on track to comm...

Palisade Bio's PALI-2108 Demonstrates Loca...
05/21/2024 12:41:08

Data presented at Digestive Disease Week (DDW) 2024Preclinical data demonstrate PALI-2108 to be safe, effective, and well toler...

Palisade Bio Q1 EPS $(4.59) Misses $(4.28)...
05/14/2024 12:36:04

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(4.59) per share which missed the analyst consensus estimate of $(4.28...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
05/03/2024 20:31:06

Palisade Bio Announces $4M Private Placeme...
05/02/2024 12:31:29

why-amd-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why AMD Shares Are Trading Lower By Around...
05/01/2024 17:01:56

Maxim Group Reiterates Buy on Palisade Bio...
05/01/2024 16:50:00

Maxim Group analyst Naz Rahman reiterates Palisade Bio (NASDAQ:PALI) with a Buy and maintains $22.5 price target.

US Stocks Mixed; Amazon Posts Upbeat Earnings
05/01/2024 13:51:59

Market-Moving News for May 1 st
05/01/2024 12:44:43

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

Market-Moving News for May 1st
05/01/2024 12:41:28

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

Palisade Bio Announces Completion Of An An...
05/01/2024 12:31:51